Portolan Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-52,389
| Closed | -$2.62M | – | 149 |
|
|
2016
Q3 | $2.62M | Buy |
+52,389
| New | +$2.62M | 0.36% | 82 |
|
|
2016
Q2 | – | Sell |
-28,858
| Closed | -$1.9M | – | 127 |
|
|
2016
Q1 | $1.9M | Buy |
+28,858
| New | +$1.9M | 0.25% | 100 |
|
|
2015
Q4 | – | Sell |
-56,502
| Closed | -$3.78M | – | 145 |
|
|
2015
Q3 | $3.78M | Sell |
56,502
-27,930
| -33% | -$1.87M | 0.5% | 81 |
|
|
2015
Q2 | $8.21M | Buy |
84,432
+15,846
| +23% | +$1.54M | 1.15% | 27 |
|
|
2015
Q1 | $6.41M | Sell |
68,586
-8,600
| -11% | -$804K | 1.18% | 25 |
|
|
2014
Q4 | $6.86M | Buy |
77,186
+23,426
| +44% | +$2.08M | 1.37% | 23 |
|
|
2014
Q3 | $3.71M | Buy |
+53,760
| New | +$3.71M | 0.84% | 52 |
|